Insiders Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 18/09/2024 BST			5-day change	1st Jan Change
20.78 ^USD	+3.85%		-0.76%	-32.09%

09-10	Arrowhead Pharmaceuticals' Plozasiran Receives FDA Breakthrough Therapy Designation	MT
09-10	Arrowhead Pharmaceuticals Gets FDA Breakthrough Designation for Plozasiran	DJ

Insiders

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

100% Free Registration

Arrowhead Pharmaceuticals, Inc. Appoints Hongbo Lu as Independent Director, Effective April 1, 2024	02-22	CI
Arrowhead Pharmaceuticals Insider Sold Shares Worth $1,860,019, According to a Recent SEC Filing	02-02	MT
Arrowhead Pharmaceuticals, Inc. Announces Leaving of Javier San Martin, M.D., as the Chief Medical Officer, Effective from February 1, 2024	01-22	CI
Arrowhead Pharmaceuticals Insider Sold Shares Worth $292,804, According to a Recent SEC Filing	01-08	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $567,910, According to a Recent SEC Filing	01-08	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $342,480, According to a Recent SEC Filing	12-22	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $567,315, According to a Recent SEC Filing	11-22	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $589,223, According to a Recent SEC Filing	30/10/23	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $1,624,223, According to a Recent SEC Filing	21/09/23	MT
Insider Sell: Arrowhead Pharmaceuticals	08/05/23	MT
Arrowhead Pharmaceuticals, Inc. Announces Resignation of Marianne De Backer, Director, Effective as of April 2, 2023	14/02/23	CI
Insider Sell: Arrowhead Pharmaceuticals	03/01/23	MT
Arrowhead Pharmaceuticals, Inc. Appoints Patrick O’Brien as Chief Operating Officer	20/07/22	CI
Arrowhead Pharmaceuticals, Inc. Appoints Victoria Vakiener to Board of Directors	02/05/22	CI
Insider Sell: Arrowhead Pharmaceuticals	14/02/22	MT
Insider Sell: Arrowhead Pharmaceuticals	10/01/22	MT
Insider Sell: Arrowhead Pharmaceuticals	07/01/22	MT
Insider Sell: Arrowhead Pharmaceuticals	07/01/22	MT
Insider Sell: Arrowhead Pharmaceuticals	20/12/21	MT
Insider Sell: Arrowhead Pharmaceuticals	22/11/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Biotechnology & Medical Research

Insiders

Filters